InvestorsHub Logo
Followers 2
Posts 133
Boards Moderated 0
Alias Born 11/12/2010

Re: None

Thursday, 10/04/2012 9:39:25 AM

Thursday, October 04, 2012 9:39:25 AM

Post# of 18496
ANESRI, it might be rewarding to manufacture a diagnostic test device that combines the ELLSA where viral particles are collected with deep sequencing biosensors that immediately identify those particles. These biosensors might even employ oscillating microscopic beads on a chip that you previously referenced. Such a diagnostic device would be invasive with the insertion of a CVP line connected to a HP if and when the HP becomes an adjunct to SOC for severe viremia where an unacceptable mortality rate is suspected (e.g. Ebola, West Nile, the Yosemite hantavirus, etc.). Collecting viral particles through ELLSA for deep sequencing would be useful in identifying the specific viral etiology in addition to attacking the viremia. I can envision such a future device being used in ERs when patients present with severe symptoms strongly suggesting a viral etiology.
I am enjoying reading your references.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News